Cargando…

Cutaneous Findings in Neurofibromatosis Type 1

SIMPLE SUMMARY: Neurofibromatosis type 1 (NF1) is characterized by major and minor cutaneous findings, whose recognition plays a key role in the early diagnosis of the disease. The disease affects multiple systems and clinical manifestation has a wide range of variability. Symptoms and clinical sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozarslan, Bengisu, Russo, Teresa, Argenziano, Giuseppe, Santoro, Claudia, Piccolo, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865571/ https://www.ncbi.nlm.nih.gov/pubmed/33530415 http://dx.doi.org/10.3390/cancers13030463

Ejemplares similares

Natalizumab-Induced Pustular Psoriasis of Palms and Soles
por: Ozarslan, Bengisu, et al.
Publicado: (2022)

Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders
por: Giugliano, Teresa, et al.
Publicado: (2019)

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
por: Santoro, Claudia, et al.
Publicado: (2018)

Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype–Phenotype Correlations
por: Peduto, Cristina, et al.
Publicado: (2023)

Recent advances in dermoscopy
por: Russo, Teresa, et al.
Publicado: (2016)

Ring Pressure Sign: When Long Lasting Dermoscopic Observation Leads the Decision
por: Piccolo, Vincenzo, et al.
Publicado: (2021)

Treatment of Cutaneous Neurofibromas in Patients with Neurofibromatosis Type 1
por: Wozniak, Bartosz, et al.
Publicado: (2023)

Polysomnographic study in pediatric neurofibromatosis type 1
por: Carotenuto, Marco, et al.
Publicado: (2023)

Perinevic dermatosis neglecta: clinical and dermoscopic description
por: Piccolo, Vincenzo, et al.
Publicado: (2019)

Subungual exostosis in an 8-year-old child: clinical and dermoscopic description
por: Piccolo, Vincenzo, et al.
Publicado: (2019)

Radiofrequency Ablation and Excision of Multiple Cutaneous Lesions in Neurofibromatosis Type 1
por: Kim, Seong-Hun, et al.
Publicado: (2013)

Clinical picture and treatment of cutaneous lesions in patients with neurofibromatosis type 1
por: Fijałkowska, Marta, et al.
Publicado: (2020)

Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1
por: Yasuda, Ken‐ichi, et al.
Publicado: (2020)

Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1
por: Santoro, Claudia, et al.
Publicado: (2018)

Neurofibromatosis Type 1: Review of Cutaneous and Subcutaneous Tumor Treatment on Quality of Life
por: Taylor, Lawrence A., et al.
Publicado: (2019)

No One Should Die of Melanoma: Time for This Vision to Be Realized?
por: Russo, Teresa, et al.
Publicado: (2019)

Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome
por: D’Amico, Alessandra, et al.
Publicado: (2020)

An Update on Neurofibromatosis Type 1-Associated Gliomas
por: Lobbous, Mina, et al.
Publicado: (2020)

Cerebral Vasculopathy in Children with Neurofibromatosis Type 1
por: Lehman, Laura L., et al.
Publicado: (2023)

Novel and Unusual Retinal Findings in Two Patients with Neurofibromatosis Type 1
por: Kilgore, David A., et al.
Publicado: (2020)

Neurofibromatosis type 1
por: Mançano, Alexandre Dias
Publicado: (2022)

Poikiloderma With Neutropenia and Mastocytosis: A Case Report and a Review of Dermatological Signs
por: Piccolo, Vincenzo, et al.
Publicado: (2021)

The Impact of Novel Coronavirus on Dermatology
por: Piccolo, Vincenzo, et al.
Publicado: (2020)

Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art
por: Bassi, Andrea, et al.
Publicado: (2021)

Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1
por: Rozza-de-Menezes, Rafaela E., et al.
Publicado: (2017)

Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report
por: ISHIDA, MITSUAKI, et al.
Publicado: (2013)

Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study
por: Cannon, Ashley, et al.
Publicado: (2018)

Medullary unidentified bright objects in Neurofibromatosis type 1: a case series
por: D’Amico, Alessandra, et al.
Publicado: (2018)

Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis
por: Tamura, Ryota
Publicado: (2021)

Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments
por: Poplausky, Dina, et al.
Publicado: (2023)

Imaging Findings of Jugular Foramen Meningocele in a Neurofibromatosis Type 1 Patient
por: Serindere, Mehmet, et al.
Publicado: (2017)

NFB-17. "Optic Pathway findings in children with Neurofibromatosis type-1 (NF-1)
por: Roka, Kleoniki, et al.
Publicado: (2022)

Plexiform neurofibromatosis type 1
por: Sharma, Surendra K., et al.
Publicado: (2016)

Neurofibromatosis Type 1 in the Mandible
por: Uchiyama, Yuka, et al.
Publicado: (2018)

Hemostasis and Type 1 Neurofibromatosis
por: Niddam, Jeremy, et al.
Publicado: (2017)

Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient
por: Serafini, Natália Battisti, et al.
Publicado: (2017)

Cranio-orbital-temporal neurofibromatosis: An uncommon subtype of neurofibromatosis type-1
por: Acharya, Nibedita, et al.
Publicado: (2014)

Current concepts of neurofibromatosis type 1: pathophysiology and treatment
por: Choi, Jaemin, et al.
Publicado: (2022)

Legius Syndrome and its Relationship with Neurofibromatosis Type 1
por: DENAYER, Ellen, et al.
Publicado: (2020)

Challenging facial pigmented lesions: values and limits of confocal microscopy
por: Agozzino, Marina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ceajdvef44ics29v4baephqkhk